Ju Chen Selected Research

Zj6413

5/2016

Poly (ADP-ribose) polymerases inhibitor, Zj6413, as a potential therapeutic agent against breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ju Chen Research Topics

Disease

21	Cardiomyopathies (Cardiomyopathy) 01/2022 - 03/2002
14	Neoplasms (Cancer) 11/2019 - 08/2009
13	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022 - 03/2002
11	Heart Failure 01/2020 - 03/2002
7	Heart Diseases (Heart Disease) 01/2019 - 04/2010
7	Muscular Diseases (Myopathy) 01/2018 - 11/2007
6	Inflammation (Inflammations) 01/2022 - 01/2007
5	Carcinogenesis 01/2022 - 04/2010
5	Hypertrophy 10/2015 - 01/2004
5	Fibrosis (Cirrhosis) 11/2014 - 03/2002
5	Cardiomegaly (Heart Hypertrophy) 12/2013 - 01/2006
4	Body Weight (Weight, Body) 10/2016 - 01/2006
3	Vascular Remodeling 01/2020 - 05/2012
3	Cardiac Arrhythmias (Arrythmia) 01/2020 - 02/2013
3	Breast Neoplasms (Breast Cancer) 01/2020 - 05/2002
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2018 - 03/2012
3	Congenital Heart Defects (Congenital Heart Defect) 01/2018 - 04/2014
3	Neoplasm Metastasis (Metastasis) 05/2016 - 05/2007
3	Insulin Resistance 01/2015 - 01/2009
2	Infections 01/2022 - 12/2013
2	Hyperglycemia 01/2022 - 01/2020
2	Esophageal Squamous Cell Carcinoma 01/2020 - 01/2014
2	Hypoxia (Hypoxemia) 01/2020 - 07/2008
2	Vascular System Injuries 01/2020 - 11/2016
2	Neointima 01/2020 - 11/2016
2	Diabetes Mellitus 01/2020 - 01/2015
2	Colorectal Neoplasms (Colorectal Cancer) 11/2019 - 01/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 05/2007
2	Reperfusion Injury 12/2018 - 12/2013
2	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 01/2017
2	Wounds and Injuries (Trauma) 01/2017 - 01/2016
2	Ganglion Cysts (Ganglion) 04/2016 - 08/2007
2	Glucose Intolerance 01/2015 - 01/2009
1	Weight Gain 01/2022
1	Hypoglycemia (Reactive Hypoglycemia) 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Critical Illness (Critically Ill) 01/2022
1	Cystic Fibrosis (Mucoviscidosis) 01/2022
1	Colitis 01/2022
1	Stomach Neoplasms (Stomach Cancer) 09/2021
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 05/2019

Drug/Important Bio-Agent (IBA)

32	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2002
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 03/2002
5	Cisplatin (Platino)FDA LinkGeneric 09/2021 - 03/2012
5	Transcription Factors (Transcription Factor)IBA 01/2018 - 04/2014
5	Protein Isoforms (Isoforms)IBA 11/2016 - 11/2007
5	CalciumIBA 09/2015 - 01/2004
4	MicroRNAs (MicroRNA)IBA 09/2021 - 03/2015
4	CytokinesIBA 11/2019 - 02/2013
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 08/2009
3	Phosphotransferases (Kinase)IBA 01/2020 - 05/2009
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2015
3	neurofilament protein LIBA 02/2016 - 03/2012
3	DystrophinIBA 10/2015 - 01/2007
3	CalcineurinIBA 10/2015 - 05/2011
2	Circular RNAIBA 01/2020 - 10/2017
2	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2020 - 05/2009
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020 - 01/2009
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2020 - 05/2009
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2019
2	Leucine (L-Leucine)FDA Link 01/2019 - 03/2018
2	Temozolomide (Temodar)FDA LinkGeneric 01/2018 - 05/2016
2	3- (5- tert- butylisoxazol- 3- yl)- 2- ((3- chlorophenyl)hydrazono)- 3- oxopropionitrileIBA 11/2016 - 11/2013
2	Biomarkers (Surrogate Marker)IBA 02/2016 - 09/2014
2	cysteine and glycine-rich protein 3IBA 01/2016 - 10/2015
2	IntegrinsIBA 01/2016 - 03/2002
2	Cytoskeletal ProteinsIBA 10/2015 - 02/2009
2	Myosins (Myosin)IBA 09/2015 - 04/2012
2	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2014 - 05/2009
2	Peptide Hydrolases (Proteases)FDA Link 12/2013 - 01/2007
2	Protein Kinase CIBA 05/2011 - 02/2004
2	beta CateninIBA 04/2010 - 08/2008
2	Biological ProductsIBA 04/2010 - 08/2009
2	Focal Adhesion Protein-Tyrosine KinasesIBA 05/2008 - 01/2006
1	FilaminsIBA 01/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022
1	atrophin-1IBA 01/2022
1	Dextran SulfateIBA 01/2022
1	ActininIBA 01/2022
1	Peptide Elongation Factor 1 (EF-1)IBA 10/2021
1	Sincalide FDA Link 09/2021
1	LuciferasesIBA 09/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2020
1	TropomyosinIBA 01/2020
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2020
1	AcetylglucosamineIBA 01/2020
1	Protein Kinases (Protein Kinase)IBA 01/2020
1	Chaperonin 60IBA 01/2020
1	Leucine-Rich Repeat ProteinsIBA 01/2020
1	ChemokinesIBA 11/2019
1	Interleukin-10 (Interleukin 10)IBA 11/2019
1	Interleukin-17 (Interleukin 17)IBA 11/2019
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 05/2019

Therapy/Procedure

5	Therapeutics 11/2019 - 01/2014
4	Drug Therapy (Chemotherapy) 09/2021 - 03/2012
2	Ligation 01/2020 - 11/2016
1	Transcutaneous Electric Nerve Stimulation (TENS) 01/2022
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022
1	Immunotherapy 11/2019